PCI Pharma Services   Report issue

For profit Phase 1 Phase 3
Founded: Philadelphia PA United States (2012)

Organization Overview

First Clinical Trial
2014
NCT02243683
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Packaging Coordinators Inc | PCI pharma services (formerly BIOTEC SERVICES INTERNATIONAL LIMITED)

Active Ingredients

Drugs in Phase 3 Trials (3)

Key: PCI Pharma Services (1) Acquired (2)

estradiol (progynon depot) (1 trial)

riboflavin (1 trial)

sodium chloride (1 trial)

Drugs in Phase 1 Trials (1)

ax-024 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 3)

Psychotic Disorders (Phase 3)

Schizophrenia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4